Evidence map›Paper›PMID 41219820›Full record

ReviewEuropean journal of medical research2025

A novel approach to the prevention and management of cardiovascular diseases: targeting brain-heart axis.

Zheng Rong, Chenchen Meng, Xinyi Li, Xinyi Li, Yangyang Gu, Yulan Li, Wei Mao

Abstract readReview
In one paragraph

Review in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zheng Rong *The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Chenchen Meng *The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Xinyi LiKey Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Xinyi LiDepartment of Cardiology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, 310013, Zhejiang, China.
Yangyang GuThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Yulan LiKey Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China. yulli90@126.com.
Wei MaoDepartment of Cardiology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, 310013, Zhejiang, China. Maoweilw@163.com.

Funding

Key Technologies Research and Development Program 2023YFC3606201National Natural Science Foundation of China 82174150, 2021
6 · The paper itself

Abstract

Epidemiological studies indicate that cardiovascular diseases are the leading cause of death and disability worldwide, imposing a significant socioeconomic burden. Despite continuous medical advancements and new preventive measures offering new prospects for the treatment of cardiovascular diseases, the incidence and mortality rates remain high, presenting a challenging outlook for prevention and treatment. Exploring new strategies for preventing and treating cardiovascular diseases has become particularly urgent. The recent research has shown a close relationship between heart health and brain health. The autonomic neural central network in the brain regulates heart function through efferent activities. Cardiac dysfunction leads to afferent remodeling of the heart, adversely affecting central neural circuits and impairing higher brain functions, hence giving rise to the "brain-heart axis" concept. In the recent years, the concept of the brain-heart axis has been further refined into the brain-heart axis and heart-brain axis. The brain-heart axis has become a new target for preventing and treating cardiovascular diseases. Establishing a comprehensive theoretical and mechanistic framework of the brain-heart axis is essential for enhancing our systematic understanding of the pathophysiological mechanisms of cardiovascular diseases and finding new therapeutic approaches. We will explore brain-heart interactions, including ischemic stroke-induced, stress-induced, and neurodegenerative cardiac damage, and discuss the potential mechanisms behind these interactions. In addition, we will summarize research on targeted brain function activity detection and cardiovascular disease prevention, aiming to provide references for future in-depth research and precision treatment in targeting brain regions for cardiovascular disease prevention.

Indexed as

BrainCardiovascular DiseasesHeartHumansBrain–heart axisBrain regionsCardiovascular diseases

Identifiers

PMID41219820
PMCPMC12606839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.